Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Sapporo Clinical Laboratory, Inc. ?
1
Company has very low debt and has enough cash to service the debt requirements
2
Poor long term growth as Operating profit has grown by an annual rate 7.22% of over the last 5 years
3
Positive results in Jun 25
- RAW MATERIAL COST(Y) Fallen by -0.75% (YoY)
4
With ROE of 4.16%, it has a very attractive valuation with a 0.38 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 101.23%, its profits have risen by 54.4% ; the PEG ratio of the company is 0.2
5
Market Beating Performance
- The stock has generated a return of 101.23% in the last 1 year, much higher than market (Japan Nikkei 225) returns of 28.54%
How much should you hold?
- Overall Portfolio exposure to Sapporo Clinical Laboratory, Inc. should be less than 10%
- Overall Portfolio exposure to Retailing should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
2.66%
EBIT Growth (5y)
7.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.59
Tax Ratio
34.55%
Dividend Payout Ratio
15.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.91%
ROE (avg)
6.69%
Valuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.38
EV to EBIT
2.17
EV to EBITDA
1.53
EV to Capital Employed
0.30
EV to Sales
0.14
PEG Ratio
0.17
Dividend Yield
NA
ROCE (Latest)
13.67%
ROE (Latest)
4.16%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
Technical Movement
1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -0.75% (YoY
-11What is not working for the Company
NET PROFIT(Q)
At JPY 47.8 MM has Fallen at -59.29%
INVENTORY TURNOVER RATIO(HY)
Lowest at 18.5%
PRE-TAX PROFIT(Q)
At JPY 93.08 MM has Fallen at -47.45%
DEBT-EQUITY RATIO
(HY)
Highest at -10.87 %
EPS(Q)
Lowest at JPY 15.32
Here's what is working for Sapporo Clinical Laboratory, Inc.
Raw Material Cost
Fallen by -0.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at JPY 160.71 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Sapporo Clinical Laboratory, Inc.
Net Profit
At JPY 47.8 MM has Fallen at -59.29%
over average net sales of the previous four periods of JPY 117.4 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Pre-Tax Profit
At JPY 93.08 MM has Fallen at -47.45%
over average net sales of the previous four periods of JPY 177.11 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (JPY MM)
Inventory Turnover Ratio
Lowest at 18.5% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Pre-Tax Profit
Lowest at JPY 93.08 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (JPY MM)
Net Profit
Lowest at JPY 47.8 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
EPS
Lowest at JPY 15.32
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (JPY)
Debt-Equity Ratio
Highest at -10.87 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






